Menu

• Ask a Health Expert about BACTERIA SPUTUM IDENTIFIED
• Post Your Side Effect related to BACTERIA SPUTUM IDENTIFIED
• BACTERIA SPUTUM IDENTIFIED and FDA Warnings
• BACTERIA SPUTUM IDENTIFIED in Patients Wiki
• Report BACTERIA SPUTUM IDENTIFIED in Drug Side Effect Survey

BACTERIA SPUTUM IDENTIFIED side effect

What is BACTERIA SPUTUM IDENTIFIED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Mycophenolate Side Effects Report #5594289-3
Health Professional from CHINA reported MYCOPHENOLATE MOFETIL problem on Jan 04, 2008. Male patient, 50 years of age, was diagnosed with immunosuppression, tuberculosis and was treated with MYCOPHENOLATE MOFETIL. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, depression, hepatotoxicity, staphylococcal infection, tuberculosis, . MYCOPHENOLATE MOFETIL dosage: unknown. During the same period patient was treated with PREDNISONE, TACROLIMUS, OFLOXACIN, ISONIAZID, RIFAPENTINE, ETHAMBUTOL HYDROCHLORIDE. Patient recovered.

Ibuprofen Side Effects Report #5538449-6
IBUPROFEN problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 23, 2007. Female patient, 33 years of age, was diagnosed with depression and was treated with IBUPROFEN. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, cardiac arrest, convulsion, electromechanical dissociation, grand mal convulsion, haemophilus infection, iatrogenic injury, loss of consciousness, . IBUPROFEN dosage: unknown. During the same period patient was treated with ACETAMINOPHEN, AMITRIPTYLINE, AMIODARONE, PHENYTOIN, EPINEPHRINE, CEFOTAXIME, HYDROCORTISONE, DIURETICS. Patient was hospitalized. Patient recovered.

Tiotropium Side Effects Report #5510618-0
Consumer or non-health professional from reported TIOTROPIUM problem on Nov 05, 2007. Male patient, 67 years of age, was diagnosed with chronic obstructive pulmonary disease and was treated with TIOTROPIUM. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, blood pressure increased, cardiac disorder, cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, fungus sputum test positive, haematocrit increased, haemoglobin increased, . TIOTROPIUM dosage: unknown. Patient was hospitalized. Patient recovered.

Byetta Side Effects Report #5483652-7
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2007. Female patient, weighting 185.0 lb, was diagnosed with type 2 diabetes mellitus, asthma, pneumonia and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, chills, decreased appetite, early satiety, pneumonia, pyrexia, urticaria, vomiting, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, ADVAIR DISKUS, SINGULAIR, LEVALBUTEROL HYDROCHLORIDE, PREDNISONE, VANCOMYCIN. Patient was hospitalized. Patient recovered.


Methotrexate Side Effects Report #5417919-5
Consumer or non-health professional from AUSTRALIA reported METHOTREXATE problem on July 25, 2007. Female patient, 61 years of age, was diagnosed with rheumatoid arthritis and was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, blood albumin decreased, blood creatinine abnormal, blood urea increased, bone marrow failure, cough, diarrhoea, epistaxis, . METHOTREXATE dosage: 7.5 MG/WEEK ORAL. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, DICLOFENAC, MYSTECLIN. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5378380-2
FLUDARABINE PHOSPHATE problem was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2007. Male patient, weighting 147.0 lb, was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, herpes zoster, methicillin-resistant staphylococcal aureus test positive, urinary tract infection staphylococcal, . FLUDARABINE PHOSPHATE dosage: 225 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

Fludarabine Side Effects Report #5378380-2
Consumer or non-health professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on July 02, 2007. Male patient, weighting 147.0 lb, was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, herpes zoster, methicillin-resistant staphylococcal aureus test positive, urinary tract infection staphylococcal, . FLUDARABINE PHOSPHATE dosage: 225 MG. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5305775-5
FORTEO problem was reported by a Consumer or non-health professional from FRANCE on Apr 11, 2007. Female patient, 86 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: bacteria sputum identified, haemoptysis, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Ambisome Side Effects Report #5567378-7
Physician from JAPAN reported AMBISOME problem on Nov 28, 2007. Male patient, 79 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: anaemia, bacteria sputum identified, beta haemolytic streptococcal infection, bronchopulmonary aspergillosis, cardiac failure, corynebacterium infection, disseminated intravascular coagulation, fungus sputum test positive, hypoalbuminaemia, . AMBISOME dosage: 100 MG. During the same period patient was treated with SOLDEM. Patient died on 08/07/2007.


Clofarabine Side Effects Report #5287001-9
CLOFARABINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 15, 2007. Female patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia recurrent, bacteria sputum identified, diarrhoea, disseminated intravascular coagulation, hypoxia, lower respiratory tract infection, lung infection, mucosal inflammation, neutropenic sepsis, . CLOFARABINE dosage: 20 MG/M2 QD IV. During the same period patient was treated with CYTARABINE. Patient died on 12/07/2006.

Zeffix Side Effects Report #5608004-8
Consumer or non-health professional from GERMANY reported ZEFFIX problem on Jan 28, 2008. Male patient, 81 years of age, was diagnosed with hepatitis b, ascites and was treated with ZEFFIX. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria sputum identified, bronchitis, cough, gamma-glutamyltransferase increased, pruritus, . ZEFFIX dosage: 100MG PER DAY. During the same period patient was treated with CANDESARTAN CILEXETIL HYDROCHLOROTHIAZIDE, TAMSULOSIN. Patient recovered.

Ambisome Side Effects Report #5731979-3
AMBISOME problem was reported by a Health Professional from JAPAN on Apr 21, 2008. Female patient, 74 years of age, weighting 110.2 lb, was diagnosed with systemic mycosis, pneumocystis jiroveci pneumonia, staphylococcal infection and was treated with AMBISOME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacteria sputum identified, blood alkaline phosphatase increased, blood beta-d-glucan increased, blood calcium decreased, blood creatine phosphokinase decreased, blood glucose increased, blood lactate dehydrogenase increased, . AMBISOME dosage: 250 MG, UID/QD, IV NOS. During the same period patient was treated with BACTRIM DS, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN HYDROCHLORIDE, MEROPENEM TRIHYDRATE, ANTITHROMBIN III, HEPARIN. Patient recovered.